3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Tissue Adhesions
1
Sezary Syndrome
1
Polyps
1
Pleural Effusion, Malignant
1
Myoma
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Endometritis
1
Breast Neoplasms
1
Interventions
Mycophenolic Acid
7
fludarabine phosphate
6
Radiotherapy
6
Cyclophosphamide
6
Antilymphocyte Serum
6
Rituximab
5
Peripheral Blood Stem Cell Transplantation
5
Filgrastim
5
Cyclosporine
5
Whole-Body Irradiation
4
Tacrolimus
4
Flow Cytometry
4
Etoposide
4
Cord Blood Stem Cell Transplantation
4
Busulfan
4
tanespimycin
3
Methotrexate
3
Melphalan
3
Lenalidomide
3
Bortezomib
3
plerixafor
2
nelarabine
2
mogamulizumab
2
aldesleukin
2
Vincristine
2
Polymerase Chain Reaction
2
Photopheresis
2
Moxifloxacin
2
Magnetic Resonance Spectroscopy
2
Immunosuppression Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Sezary Syndrome
×
Doxycycline
×
Clear all
NCT02341209
2021-04-27
CTCL
Rochester General Hospital
Phase 2
Terminated
1 enrolled